Dr. Rachel Issaka pointed out health disparities in colorectal cancer survival.
Dr. Joe Unger explained additional benefits of publicly-funded cancer clinical trials.
Dr. Joe Unger commented on a study he led on treatment-associated adverse events by sex.
Dr. Jonathan Bricker discussed smoking cessation.
Dr. Joe Unger shared his hopes for the treatment of cancer patients.
Dr. Heather Greenlee discussed her new study on breast cancer and cardiovascular risk.
Dr. Veena Shankaran and coauthors urged more support for people with cancer.
Dr. Joe Unger discussed future research building on a study he led.
Dr. Veena Shankaran shared findings from a recent study.
Kathy Briant and Dr. Rachel Issaka discussed how the pandemic has reduced cancer screenings.
Dr. Rachel Issaka was featured as one of PSBJ's 40 under 40.
Dr. Scott Ramsey commented on how the standard treatment for sickle cell disease is more costly than a new curative approach.
Dr. Riki Peters and collaborators spoke about new research to understand colorectal cancer disparities in Alaska Native people.
Dr. Jonathan Bricker shared strategies for quitting smoking.
Dr. Parth Shah discussed his study on how to encourage HPV vaccination.
Dr. Joe Unger discussed efforts to measure whether changes to clinical trials during the pandemic affected data quality.
Dr. Rachel Issaka gave insights on the new guidelines for colonoscopies.
Dr. Rachel Issaka critiqued a study’s consent process.
Dr. Joe Unger explained his study showing that in cancer patients, “access to guideline-based care...alone is not sufficient to eliminate disparate outcomes related to socioeconomic deprivation.”
Dr. Heather Greenlee described her goal for the Cook for Your Life website.
Dr. Rachel Issaka described how patients should approach at-home colon cancer tests with their doctors.
Dr. Scott Ramsey discussed how some of the changes to health care during the pandemic may result in improved quality of care and greater efficiency.
Dr. Rachel Issaka spoke with KING 5 about how structural racism affects both doctors of color and patients.
In a Q&A, Dr. Rachel Issaka discussed how health care professionals can dismantle systemic racism in medicine, including examining “the policies and structures within medicine that make it more difficult for minority patients to thrive.”
Dr. Jonathan Bricker explained how acknowledging and accepting cravings is the key to quitting smoking.
Dr. Rachel Issaka commented on the importance of home screening tests for colorectal cancer.
Dr. Rachel Issaka discussed her recent essay on structural racism in academic medicine, and what should be done to change it.
Joseph Unger commented on his new study on the impact of insurance status on health outcomes.
Joseph Unger’s and the SWOG network's latest research illustrating that Black patients are better represented in publicly funded cancer clinical trials is discussed.
Joe Unger commented on how a lack of Black patients in clinical trials can lead to a lack of data on how drugs impact vulnerable populations.
Dr. Joe Unger’s research with the SWOG network suggesting health insurance plays a role in clinical trial success for patients is discussed.
Dr. Gary Lyman’s work with the COVID-19 and Cancer Consortium is referenced, revealing that patients with active cancer have a higher risk of death after contracting SARS-CoV-2.
New research from the Hutch's health economics group HICOR and Dr. Veena Shankaran, suggesting nearly 75% of patients with advanced colon cancer experience financial hardship as a result of treatment is discussed.
A SWOG study led by Joseph Unger is featured, specifically findings that insurance plays a large role in whether a patient benefits from clinical trials.
Dr. Gary Lyman discussed the risk cancer patients face with COVID-19 and his work with the COVID-19 and Cancer Consortium.
Rachel Issaka weighed in on the need to continue cancer and other chronic disease management and prevention work despite COVID-19.
Dr. Gary Lyman’s comments from a panel on COVID-19 and cancer care are highlighted.
Gary Lyman’s comments on the new COVID-19 cancer registry are discussed.
Dr. William Grady commented on an outside study on blood tests and cancer detection.
Dr. Gary Lyman commented on the new COVID-19 and Cancer Consortium (CCC19) registry and how they will use COVID-19 data to inform treatment.
Dr. Gary Lyman discussed best practices for treating cancer patients during the COVID-19 outbreak.
Dr. Kevin Cheung provided expert commentary on the relationship between breast cancer and nutritional supplements.
Dr. Joshua Roth discussed his study on genetic testing knowledge.
Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.
Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.
HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for
The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates.
Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.
Dr. Jaimee Heffner provided expert commentary on a new study about lung cancer screening guidelines. This story was re-printed in several other outlets, including Business Insider.
Dr. Josh Roth provided expert commentary about a study on cost of CAR-T therapy.
MedPage Today highlighted a study led by Fred Hutch’s Dr. Scott Ramsey, which showed that newly diagnosed cancer patients were unaware that they were infected with Hepatitis B and other viruses.
STAT interviewed Dr. Parth Shah on The Readout Loud podcast about his research on increasing HPV vaccination rates in the U.S.
Dr. Mario Kratz provided comments on why he reviews the latest nutrition and health books for the Red Pen Reviews website.
The Seattle Times cited Dr. Mario Kratz about the health impact of sugary beverages.
Dr. Veena Shankaran, co-director of Fred Hutch’s health care and economics policy research group, the Hutchinson Institute for Cancer Outcomes Research, commented on the impact of high-deductible health plans on people with cancer.
Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk.
CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.
CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.
KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.
KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.
Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research.
This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.
This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.
This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.
This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.
Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column.
This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency.
This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency.
Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity
This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study.
Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity
This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study.
This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive.
This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive.
This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.
This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.
This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later.
This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later.
Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today.
This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year.
Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today.
This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year.
Fred Hutch Dr. Marian Neuhouser provides expert comments on the benefits of multivitamins.
This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.
Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.
This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.
This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.
Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.
Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.
Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.
Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.
Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.
This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.
This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.
In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.
Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.
In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.
Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
Research presented at the American Society of Clinical Oncology (ASCO) and published in the New England Journal of Medicine suggests that new genetic testing may make it possible for 70 percent of early-stage breast cancer patients to avoid chemotherapy. Fred Hutch’s Dr. Kevin Cheung explained the study and its implications for patients.
Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.
Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
Dr. Marian L. Neuhouser, head of the Cancer Prevention Program at Fred Hutch, discussed possible links between soy products and breast cancer. She noted compounds found in soybeans and other plants can mimic the effects of estrogen, a prime driver of most breast cancers, but most studies have found no negative association between soy consumption and breast cancer risk.
A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.
A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.
Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.
Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.
For women experiencing sleep disturbances associated with menopause, talking with a sleep coach and adopting personalized advice and tools was more effective than other measures aimed at improving sleep, according to Dr. Katherine Guthrie of the Public Health Sciences Division, who led a study that appeared in the journal Sleep.
For women experiencing sleep disturbances associated with menopause, talking with a sleep coach and adopting personalized advice and tools was more effective than other measures aimed at improving sleep, according to Dr. Katherine Guthrie of the Public Health Sciences Division, who led a study that appeared in the journal Sleep.
In a Seattle Times opinion article on racial disparities in treatment and outcomes, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, and Dr. Beti Thompson, director of the Health Disparities Research Center, said clinical trials often fail to include people of color, and black women have too little access to information and services.
In a Seattle Times opinion article on racial disparities in treatment and outcomes, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, and Dr. Beti Thompson, director of the Health Disparities Research Center, said clinical trials often fail to include people of color, and black women have too little access to information and services.
Dr. Scott Ramsey and Dr. Gary Lyman, leaders of the Hutchinson Institute for Cancer Outcomes Research, were quoted in an NPR story on expensive, painful and unnecessary tests and treatments that many women with breast cancer endure. This story originally appeared in Kaiser Health News.
Dr. Scott Ramsey and Dr. Gary Lyman, leaders of the Hutchinson Institute for Cancer Outcomes Research, were quoted in an NPR story on expensive, painful and unnecessary tests and treatments that many women with breast cancer endure. This story originally appeared in Kaiser Health News.
Dr. Scott Ramsey, co-director of the Hutchinson Center for Cancer Outcomes Research, or HICOR, was quoted in an article about the lack of patients available to participate in immunotherapy clinical trials
Dr. Scott Ramsey, co-director of the Hutchinson Center for Cancer Outcomes Research, or HICOR, was quoted in an article about the lack of patients available to participate in immunotherapy clinical trials
An interview with Dr. Joseph Unger on the effectiveness of SWOG, a federal clinical trial consortium of which Fred Hutch is a leading member
An interview with Dr. Joseph Unger on the effectiveness of SWOG, a federal clinical trial consortium of which Fred Hutch is a leading member
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Dr. Michael Emerman was quoted in an article on transposable elements in genomes that can jump around chromosomes, contribute to life-threatening diseases and come from dormant viruses
Dr. Michael Emerman was quoted in an article on transposable elements in genomes that can jump around chromosomes, contribute to life-threatening diseases and come from dormant viruses
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
Article covers study led by Dr. Polly Newcomb indicating that use of nonsteroidal anti-inflammatory drugs can increase survival rate in colorectal cancer patients without KRAS wild-type tumors
Article covers study led by Dr. Polly Newcomb indicating that use of nonsteroidal anti-inflammatory drugs can increase survival rate in colorectal cancer patients without KRAS wild-type tumors
Article on several cancers that men should be aware of, including comments from Dr. William Grady on symptoms and treatment for colorectal cancer
Article on several cancers that men should be aware of, including comments from Dr. William Grady on symptoms and treatment for colorectal cancer
Coverage of the Fred Hutch-led study that found trials run by the SWOG collaborative group saved an estimated 3.34 million years of life for cancer patients. Quotes study author Dr. Joseph Unger
Coverage of the Fred Hutch-led study that found trials run by the SWOG collaborative group saved an estimated 3.34 million years of life for cancer patients. Quotes study author Dr. Joseph Unger
Fred Hutch-led study found that trials run by the National Cancer Institute-supported SWOG collaborative group have saved an estimated 3.34 million years of life. Article quotes study author Dr. Joseph Unger on how the team measured the program's benefit
Fred Hutch-led study found that trials run by the National Cancer Institute-supported SWOG collaborative group have saved an estimated 3.34 million years of life. Article quotes study author Dr. Joseph Unger on how the team measured the program's benefit
Fred Hutch biostatistician Dr. Ross Prentice comments on a controversial study on the role DNA mutations play in cancer risk. Scientific American also ran this story
Fred Hutch biostatistician Dr. Ross Prentice comments on a controversial study on the role DNA mutations play in cancer risk. Scientific American also ran this story
Quotes Dr. Marion Neuhouser on a study that found some positive benefits of soy consumption among breast cancer survivors
Quotes Dr. Marion Neuhouser on a study that found some positive benefits of soy consumption among breast cancer survivors
Article on breast cancer and exercise study quotes Dr. Anne McTiernan
Julia Walker, a member of the Hutchinson Institute for Cancer Outcomes Research, is quoted explaining a study looking into why breast cancer patients may be receiving biomarker testing or imaging that doesn't adhere to recommendations
Interview with Dr. Anne McTiernan, a cancer prevention researcher at Fred Hutch who recently wrote a memoir, "Starved: A Nutrition Doctor's Journey from Empty to Full," about her early-childhood of neglect and near-starvation and how she overcame these obstacles to become a leading nutrition researcher
Dr. Sunil Hingorani, principal investigator of a trial for pancreatic cancer drug PEGPH20, is quotes on recent clinical trial results
Quotes Fred Hutch nutritional epidemiologist Dr. Marian Neuhouser
Quotes Fred Hutch health care economist Dr. Scott Ramsey about a Johns Hopkins study that found cancer patients with only Medicare coverage face steep out-of-pocket costs
Quotes Fred Hutch nutritional epidemiologist Dr. Marian Neuhouser
Quotes Fred Hutch health care economist Dr. Scott Ramsey about a Johns Hopkins study that found cancer patients with only Medicare coverage face steep out-of-pocket costs
Article about a study of an app developed by Dr. Jonathan Bricker and 2Morrow that found it could up to triple a smoker's chances of quitting
Article about a study of an app developed by Dr. Jonathan Bricker and 2Morrow that found it could up to triple a smoker's chances of quitting
Coverage of a prostate cancer study by Drs. Catherine Tangen and colleagues that was published recently in the Journal of Clinical Oncology
Coverage of a prostate cancer study by Drs. Catherine Tangen and colleagues that was published recently in the Journal of Clinical Oncology
Opinion piece by Drs. Scott Ramsey and Veena Shankaran of the Hutchinson Institute for Cancer Outcomes Research
Opinion piece by Drs. Scott Ramsey and Veena Shankaran of the Hutchinson Institute for Cancer Outcomes Research
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about confusion among breast cancer patients about follow-up care
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about confusion among breast cancer patients about follow-up care
Coverage of a $2.5 million grant to Dr. Linda Ko and colleagues at Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
Coverage of a $2.5 million grant to Dr. Linda Ko and colleagues at Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
Quotes Fred Hutch health economist Dr. Scott Ramsey
Quotes Fred Hutch health economist Dr. Scott Ramsey
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Coverage of a study by Dr. Katherine Guthrie of Fred Hutch and Dr. Susan McCurry of the University of Washington School of Nursing, published recently in JAMA Internal Medicine
Coverage of a study by Dr. Katherine Guthrie of Fred Hutch and Dr. Susan McCurry of the University of Washington School of Nursing, published recently in JAMA Internal Medicine
Quotes Dr. Mario Kratz of the Public Health Sciences Division
Coverage of a $2.5 million grant to Dr. Linda Ko of Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
Coverage of a $2.5 million grant to Dr. Linda Ko of Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
Quotes Dr. Jonathan Bricker, a smoking-cessation expert at Fred Hutch
Quotes Dr. Jonathan Bricker, a smoking-cessation expert at Fred Hutch
Profile of Hutch smoking-cessation researcher Dr. Jonathan Bricker
Profile of Hutch smoking-cessation researcher Dr. Jonathan Bricker
Quotes Dr. Anne McTiernan about newly reported risk factors for stomach cancer
Quotes Fred Hutch nutrition researcher Dr. Marian Neuhouser about the health benefits of omega 3s found in foods such as fish
Quotes Fred Hutch health economist Dr. Scott Ramsey
Article about Fred Hutch smoking-cessation researcher Dr. Jonathan Bricker and his collaboration with researchers at the University of Beijing to bring quit-smoking apps to people in China, where 315 million light up regularly and more than 1 million die from the habit each year
Quotes Fred Hutch health economist Dr. Scott Ramsey
Article about Fred Hutch smoking-cessation researcher Dr. Jonathan Bricker and his collaboration with researchers at the University of Beijing to bring quit-smoking apps to people in China, where 315 million light up regularly and more than 1 million die from the habit each year
Article about the financial toxicity of cancer quotes Fred Hutch health economist Dr. Scott Ramsey, whose research has found that people with cancer are 2.65 times more likely to file for bankruptcy that those without cancer
Article about the financial toxicity of cancer quotes Fred Hutch health economist Dr. Scott Ramsey, whose research has found that people with cancer are 2.65 times more likely to file for bankruptcy that those without cancer
Coverage of a recent JAMA Oncology paper by Dr. Joseph Unger
Coverage of a recent JAMA Oncology paper by Dr. Joseph Unger
Quotes Dr. Alan Kristal of the Public Health Sciences Division
Coverage of a recent study by Drs. Ruth Etzioni and Joshua Roth
Article about a recent study by Dr. Joe Unger, a SWOG biostatistician based in the Public Health Sciences Division at Fred Hutch
Article about a recent study by Dr. Joe Unger, a SWOG biostatistician based in the Public Health Sciences Division at Fred Hutch
Coverage of a study by Dr. Joe Unger, a biostatistician in the SWOG Statistical Center at Fred Hutch, on the positive scientific contributions of negative clinical trial results
Coverage of a study by Dr. Joe Unger, a biostatistician in the SWOG Statistical Center at Fred Hutch, on the positive scientific contributions of negative clinical trial results
Quotes cancer prevention and nutrition researcher Dr. Marian Neuhouser
Quotes cancer prevention and nutrition researcher Dr. Marian Neuhouser
Quotes Dr. Scott Ramsey about his research into the link between cancer, bankruptcy and increased mortality
Interview, in Spanish, about cancer prevention tips with Fred Hutch's Kathy Briant on World Cancer Day (interview broadcast Feb. 4, posted Feb. 12)
Quotes Fred Hutch cancer prevention expert Dr. Anne McTiernan
Interview with Fred Hutch health economists Drs. Scott Ramsey and Gary Lyman about the high cost of pharmaceutical drugs and how patients can be forced into bankruptcy in order to live
Quotes Dr. Johanna Lampe about the cancer-fighting properties of Brussels sprouts and other crucifers
Interview with Fred Hutch health economists Drs. Scott Ramsey and Gary Lyman about the high cost of pharmaceutical drugs and how patients can be forced into bankruptcy in order to live
Quotes Dr. Johanna Lampe about the cancer-fighting properties of Brussels sprouts and other crucifers
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about new guidelines for cancer survivors issued today
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about new guidelines for cancer survivors issued today
Quotes Dr. Gary Lyman of the Hutchinson Institute for Cancer Outcomes Research about his participation on a panel that aimed to provide practical recommendations for identifying and evaluating patients with cancer-related fatigue
Quotes Dr. Gary Lyman of the Hutchinson Institute for Cancer Outcomes Research about his participation on a panel that aimed to provide practical recommendations for identifying and evaluating patients with cancer-related fatigue
Coverage of a recent study by Dr. Joe Unger
Coverage of a recent study by Dr. Joe Unger
Article about a study by Dr. Joe Unger quotes him about his research
Article about a study by Dr. Joe Unger quotes him about his research
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues that found immunotherapy can improve survival by more than 75 percent in mice with pancreatic cancer
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues
Article about a study by Dr. Joe Unger
Quotes Dr. Joe Unger about his research
Quotes Dr. Joe Unger about his research
Article quotes Dr. Jonathan Bricker
Article about a study by Dr. Joe Unger
Quotes Dr. Joe Unger about his research
Quotes Dr. Joe Unger about his research
Article quotes Dr. Jonathan Bricker
Q-and-A with Dr. Jonathan Bricker about his smoking-cessation research
Quotes Dr. Lu Chen about her research
Q-and-A with Dr. Jonathan Bricker about his smoking-cessation research
Quotes Dr. Lu Chen about her research
Quotes Dr. Jonathan Bricker about the dangers of e-cigs
Quotes Dr. Jonathan Bricker about the dangers of e-cigs
Interview with Dr. Gary Gilliland, president and director of Fred Hutch, about his vision of the future of cancer care and the promise of immune-based therapies
Interview with Dr. Gary Gilliland, president and director of Fred Hutch, about his vision of the future of cancer care and the promise of immune-based therapies
Article about the challenges of growing bacteria in the lab mentions the research of Dr. David Fredricks, a bacteriologist at the Hutch
Article about the challenges of growing bacteria in the lab mentions the research of Dr. David Fredricks, a bacteriologist at the Hutch
Coverage of the first lady of China's Fred Hutch visit quotes Dr. Gary Gilliland, Fred Hutch president and director, and smoking-cessation researcher Dr. Jonathan Bricker
Coverage of the first lady of China's Fred Hutch visit quotes Dr. Gary Gilliland, Fred Hutch president and director, and smoking-cessation researcher Dr. Jonathan Bricker
Commentary by Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research, on the impact of obesity in chemotherapy dosing
Commentary by Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research, on the impact of obesity in chemotherapy dosing
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
Photos from the Obliteride fundraising event for Fred Hutch
Photos from the Obliteride fundraising event for Fred Hutch
Profile of Fred Hutch public health researcher Dr. Beti Thompson, who is training for and participating in this weekend's Obliteride, an annual cycling fundraiser for the Hutch
Profile of Fred Hutch public health researcher Dr. Beti Thompson, who is training for and participating in this weekend's Obliteride, an annual cycling fundraiser for the Hutch
Story on the African-American cancer experience focuses on breast cancer survivor and advocate Bridgette Hempstead of Cierra Sisters, who works as a consultant with Fred Hutch’s Dr. Rachel Ceballos to tailor cancer survivorship programs for minority communities. Ceballos commented that many survivors don’t deal with the emotional aspects of their diagnosis until long after treatment is over.
Story on the African-American cancer experience focuses on breast cancer survivor and advocate Bridgette Hempstead of Cierra Sisters, who works as a consultant with Fred Hutch’s Dr. Rachel Ceballos to tailor cancer survivorship programs for minority communities. Ceballos commented that many survivors don’t deal with the emotional aspects of their diagnosis until long after treatment is over.
Article quotes Dr. Scott Ramsey, director of the Hutchinson Institute for Cancer Outcomes Research
Article quotes Dr. Scott Ramsey, director of the Hutchinson Institute for Cancer Outcomes Research
Fred Hutch smoking-cessation expert Dr. Jonathan Bricker is quoted
Fred Hutch smoking-cessation expert Dr. Jonathan Bricker is quoted
Article about a company called DataStat, which helps researchers automate their workflow, mentions its clients include Fred Hutch, which uses the software to help workers in Zambia organize HIV and AIDS data collection across 21 communities
Article about a company called DataStat, which helps researchers automate their workflow, mentions its clients include Fred Hutch, which uses the software to help workers in Zambia organize HIV and AIDS data collection across 21 communities
Article about Fred Hutch spinoff company Adaptive Biotechnologies
Article about Fred Hutch spinoff company Adaptive Biotechnologies
Article about Fred Hutch's Dr. Jonathan Bricker, a smoking-cessation expert who is a finalist for GeekWire's "Geek of the Year Award"; online voting goes through the end of today
Article about Fred Hutch's Dr. Jonathan Bricker, a smoking-cessation expert who is a finalist for GeekWire's "Geek of the Year Award"; online voting goes through the end of today
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Article quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Article about a study led by Dr. Polly Newcomb
Article quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Article about a study led by Dr. Polly Newcomb
Quotes Dr. Marian Neuhouser, a Fred Hutch nutritional epidemiologist who participated in an expert panel that has updated recommendations for U.S. dietary guidelines
Quotes Dr. Marian Neuhouser about the latest U.S. dietary recommendations that she helped draft
Quotes Dr. Marian Neuhouser, a Fred Hutch nutritional epidemiologist who participated in an expert panel that has updated recommendations for U.S. dietary guidelines
Quotes Dr. Marian Neuhouser about the latest U.S. dietary recommendations that she helped draft
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Quotes Dr. Marian Neuhouser
Quotes nutritional epidemiologist Dr. Marian Neuhouser
Quotes Dr. Marian Neuhouser
Quotes nutritional epidemiologist Dr. Marian Neuhouser
Interview with Dr. Jonathan Bricker about ways to kick the smoking habit in the new year, including participating in his WebQuit.org online study (his segment starts about 16 minutes into the show and runs about 16 minutes)
Interview with Dr. Jonathan Bricker about ways to kick the smoking habit in the new year, including participating in his WebQuit.org online study (his segment starts about 16 minutes into the show and runs about 16 minutes)